De novo design by pharmacophore-based searches in fragment spaces
暂无分享,去创建一个
Matthias Rarey | Wolfgang Guba | Tobias Lippert | Tanja Schulz-Gasch | Olivier Roche | W. Guba | M. Rarey | T. Schulz-Gasch | O. Roche | Tobias Lippert
[1] Hongwei Huang,et al. E-Novo: An Automated Workflow for Efficient Structure-Based Lead Optimization , 2009, J. Chem. Inf. Model..
[2] Wolfgang Guba,et al. Integrating molecular design resources within modern drug discovery research: the Roche experience. , 2006, Drug discovery today.
[3] Gisbert Schneider,et al. Flux (1): A Virtual Synthesis Scheme for Fragment-Based de Novo Design , 2006, J. Chem. Inf. Model..
[4] Peter S Kutchukian,et al. De novo design: balancing novelty and confined chemical space , 2010, Expert opinion on drug discovery.
[5] Conrad C. Huang,et al. UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..
[6] Brian K. Shoichet,et al. Virtual screening of chemical libraries , 2004, Nature.
[7] G. Bemis,et al. BREED: Generating novel inhibitors through hybridization of known ligands. Application to CDK2, p38, and HIV protease. , 2004, Journal of medicinal chemistry.
[8] M Rarey,et al. Detailed analysis of scoring functions for virtual screening. , 2001, Journal of medicinal chemistry.
[9] Mark A. Murcko,et al. GenStar: A method for de novo drug design , 1993, J. Comput. Aided Mol. Des..
[10] Harald Mauser,et al. Chemical Fragment Spaces for de novo Design , 2007, J. Chem. Inf. Model..
[11] Thierry Langer,et al. LigandScout: 3-D Pharmacophores Derived from Protein-Bound Ligands and Their Use as Virtual Screening Filters , 2005, J. Chem. Inf. Model..
[12] Klaus R. Liedl,et al. One Concept, Three Implementations of 3D Pharmacophore-Based Virtual Screening: Distinct Coverage of Chemical Search Space , 2010, J. Chem. Inf. Model..
[13] Petra Schneider,et al. Comparison of correlation vector methods for ligand-based similarity searching , 2003, J. Comput. Aided Mol. Des..
[14] David A. Pearlman,et al. CONCEPTS: New dynamic algorithm for de novo drug suggestion , 1993, J. Comput. Chem..
[15] Matthias Rarey,et al. On the Art of Compiling and Using 'Drug‐Like' Chemical Fragment Spaces , 2008, ChemMedChem.
[16] G. Schneider,et al. Voyages to the (un)known: adaptive design of bioactive compounds. , 2009, Trends in biotechnology.
[17] Wolfgang Guba,et al. Recent developments in de novo design and scaffold hopping. , 2008, Current opinion in drug discovery & development.
[18] J. A. Grant,et al. A fast method of molecular shape comparison: A simple application of a Gaussian description of molecular shape , 1996, J. Comput. Chem..
[19] Philip M Dean,et al. Scaffold hopping in de novo design. Ligand generation in the absence of receptor information. , 2004, Journal of medicinal chemistry.
[20] Michael M. Hann,et al. RECAP-Retrosynthetic Combinatorial Analysis Procedure: A Powerful New Technique for Identifying Privileged Molecular Fragments with Useful Applications in Combinatorial Chemistry , 1998, J. Chem. Inf. Comput. Sci..
[21] Philip M. Dean,et al. Evaluation of a method for controlling molecular scaffold diversity in de novo ligand design , 1997, J. Comput. Aided Mol. Des..
[22] R. Kurumbail,et al. Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents , 1996, Nature.
[23] Gisbert Schneider,et al. Collection of bioactive reference compounds for focused library design , 2003 .
[24] John Bradshaw,et al. Similarity Searching Using Reduced Graphs , 2003, J. Chem. Inf. Comput. Sci..
[25] C. Dobson. Chemical space and biology , 2004, Nature.
[26] G. Bemis,et al. The properties of known drugs. 1. Molecular frameworks. , 1996, Journal of medicinal chemistry.
[27] Richard A. Lewis,et al. Three-dimensional pharmacophore methods in drug discovery. , 2010, Journal of medicinal chemistry.
[28] Matthias Rarey,et al. Similarity searching in large combinatorial chemistry spaces , 2001, J. Comput. Aided Mol. Des..
[29] Matthias Rarey,et al. FlexNovo: Structure‐Based Searching in Large Fragment Spaces , 2006, ChemMedChem.
[30] C. D. Gelatt,et al. Optimization by Simulated Annealing , 1983, Science.
[31] Ronald J. Gillespie,et al. The electron-pair repulsion model for molecular geometry , 1970 .
[32] Arup K. Ghose,et al. Atomic physicochemical parameters for three dimensional structure directed quantitative structure-activity relationships. 4. Additional parameters for hydrophobic and dispersive interactions and their application for an automated superposition of certain naturally occurring nucleoside antibiotics , 1989, J. Chem. Inf. Comput. Sci..
[33] Hans-Joachim Böhm,et al. The computer program LUDI: A new method for the de novo design of enzyme inhibitors , 1992, J. Comput. Aided Mol. Des..
[34] Philip M. Dean,et al. A validation study on the practical use of automated de novo design , 2002, J. Comput. Aided Mol. Des..
[35] Matthias Rarey,et al. Recore: A Fast and Versatile Method for Scaffold Hopping Based on Small Molecule Crystal Structure Conformations , 2007, J. Chem. Inf. Model..
[36] Brian B. Masek,et al. NovoFLAP: A Ligand-Based De Novo Design Approach for the Generation of Medicinally Relevant Ideas , 2010, J. Chem. Inf. Model..
[37] G. Superti-Furga,et al. Structural Basis for the Autoinhibition of c-Abl Tyrosine Kinase , 2003, Cell.
[38] Philip M. Dean,et al. A branch-and-bound method for optimal atom-type assignment in de novo ligand design , 1998, J. Comput. Aided Mol. Des..
[39] Gisbert Schneider,et al. Searching for drug scaffolds with 3D pharmacophores and neural network ensembles. , 2007, Angewandte Chemie.
[40] Gisbert Schneider,et al. Computer-based de novo design of drug-like molecules , 2005, Nature Reviews Drug Discovery.